1. Home
  2. QUIK vs MOLN Comparison

QUIK vs MOLN Comparison

Compare QUIK & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$9.43

Market Cap

139.5M

Sector

Technology

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$4.34

Market Cap

158.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
QUIK
MOLN
Founded
1988
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
139.5M
158.9M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
QUIK
MOLN
Price
$9.43
$4.34
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$11.00
$8.38
AVG Volume (30 Days)
206.0K
4.1K
Earning Date
03-03-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,112,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$70.38
$318.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.26
$3.36
52 Week High
$10.14
$5.36

Technical Indicators

Market Signals
Indicator
QUIK
MOLN
Relative Strength Index (RSI) 65.03 51.34
Support Level $5.51 $3.51
Resistance Level N/A $5.33
Average True Range (ATR) 0.79 0.27
MACD 0.04 -0.06
Stochastic Oscillator 74.32 46.82

Price Performance

Historical Comparison
QUIK
MOLN

About QUIK QuickLogic Corporation

QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: